<DOC>
	<DOCNO>NCT03024424</DOCNO>
	<brief_summary>The goal study : To assess impact genetic testing base alters behavior , assess utility serum biomarker measurement combination genetic testing , assess utility genetic counseling personal analysis risk age-related macular degeneration ( AMD ) , assess impact presymptomatic genetic test choroidal neovascularization ( CNV ) .</brief_summary>
	<brief_title>Value Genetic Counseling Testing Patients Who Would Like Know More About Their Personal Risk AMD</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>Caucasian ( particular genetic test validate Caucasians ) Participants positive family history AMD necessary . Individuals personal history AMD eligible . Noncaucasian individual eligible . Employees Moran Eye Center eligible .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>